FDA Made 9 Observations Post Halol Unit Inspection: Sun Pharma

New Delhi: Drug major Sun Pharmaceutical Industries today said that the US health regulator made nine observations after the completion of inspection of its Halol facility in Gujarat. The United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Pharma said in a BSE filing. "At the conclusion of the inspection, the USFDA issued a Form-483, citing nine inspec...